Effect of soluble PD-L1 released by lung cancer cells in regulating the function of T lymphocytes

Min-hua SHI,Yu-fei XING,Zeng-li ZHANG,Jian-an HUANG,Yong-jing CHEN

DOI: https://doi.org/10.3760/cma.j.issn.0253-3766.2013.02.002

2013-01-01

Abstract:Objective To explore the expression of soluble programmed death ligand-1 on lung cancer cells and to clarify its biological function through PD-1/PD-L1 pathway in regulating the function of T lymphocytes.Methods Labeled monoclonal antibody and flow cytometry were used to analyze the expression of PD-L1 and its receptor PD-1 on lung cancer cells and human T lymphocytes,respectively.The level of sPD-L1 in the supernatant of lung cancer cells was determined with an ELISA kit.The inhibition of proliferation of T lymphocytes by mPD-L1 and sPD-L1 was studied using CCK-8 incorporation.Results Low or no expression [(16.08 ± 2.28) ％] of PD-1 was found on resting T lymphocytes from human peripheral blood with flow cytometry,but up-regulated expression of PD-1 [(78.06 ±7.21)％] was found on the surface of activated T lymphocytes.Soluble PD-L1 was found in supernatant of some lung cancer cell lines,such as H1299,H08910,SPCA-1,H460,H446 cells,with PD-L1 expressing on their cell surface [(78.34±10.25)％,(68.17 ± 11.56)％,(45.32 ±7.98)％,(47.52 ±9.62)％ and (40.95 ±8.56)％,respectively],but very low expression on A549 cells [(16.02 ± 6.28) ％].The level of mPD-L1 on H1299 cells was highest [(78.34 ± 10.25) ％],compared with H08910 cells (68.17 ± 11.56) ％,SPCA-1 cells (45.32 ± 7.98) ％,H446 cells (40.95 ± 8.56) ％,and H460 cells (47.52 ± 9.62) ％.At the same time,the sPD-L1 level on H1299 cells was low [(0.17 ± 0.01) ng/ml],compared with HO8910 cells (0.30 ± 0.03) ng/ml,SPCA-1cells (0.59 ±0.03) ng/ml,H446 cells (0.34 ±0.02)ng/ml,and H460 cells (0.57 ±0.03)ng/ml,but not expressed on A549 cells.PD-L1 expressing H1299 cells inhibited the proliferation of T lymphocytes in the coculture system.Supernatant of the cultured PD-L1 + lung cancer cells also inhibited T cell proliferation.Antihuman PD-L1 blocking antibody could partly restore the proliferation capacity of T lymphocytes.Conclusions Membrane-bound PD-L1 and soluble PD-L1 released from lung cancer cells can effectively inhibit the proliferation of T lymphocytes in mixed culture system and down-regulate cell-mediated immunity in vitro.This may lead to inactivation of tumor antigen-specific T cells and immune escape of lung cancer cells.